# OR2A42

## Overview
OR2A42 is a gene that encodes the protein olfactory receptor family 2 subfamily A member 42, which belongs to the G-protein-coupled receptor (GPCR) superfamily. These receptors are integral membrane proteins that play a crucial role in the detection of odorant molecules, facilitating the sense of smell through signal transduction pathways. The OR2A42 protein is primarily associated with olfactory functions but is also expressed in various non-olfactory tissues, suggesting potential roles in other physiological processes such as cell migration (Mazzei2024Functional; Flegel2013Expression). While its primary function is linked to olfaction, emerging research indicates that OR2A42 may have broader implications in health and disease, including potential involvement in conditions like Type 2 Diabetes Mellitus and cancer (Alcaide2020Evaluating; MosconaNissan2024Whole). Further studies are needed to fully elucidate the diverse roles of OR2A42 in human biology.

## Function
OR2A42 is a gene that encodes an olfactory receptor protein, which is part of the G-protein-coupled receptor (GPCR) family. These receptors are primarily involved in detecting odor molecules, initiating a signal transduction pathway that results in the perception of smell. In a study using a yeast system, OR2A42 was codon-optimized for expression and screened against a panel of 57 chemicals to identify potential ligands. Farnesol was identified as a ligand for OR2A42, resulting in a 2-fold increase in signal upon activation, indicating its role in olfactory signal transduction (Yasi2019Rapid).

Beyond its role in olfaction, OR2A42 has been found to be expressed in various non-olfactory tissues, suggesting potential roles in other physiological processes. It has been implicated in promoting fibroblast migration, indicating a possible involvement in cell migration processes (Mazzei2024Functional). The gene is also broadly expressed in different human tissues, which may suggest additional functions outside the olfactory system (Flegel2013Expression). However, the specific functions of OR2A42 in healthy cells remain to be fully elucidated, and further research is needed to understand its roles in non-olfactory contexts.

## Clinical Significance
The OR2A42 gene, part of the olfactory receptor family, has been studied in various contexts, including its potential involvement in diseases. In a study analyzing genetic variants in patients with Maturity-Onset Diabetes of the Young (MODY) and Type 2 Diabetes Mellitus (T2DM), OR2A42 was found to have variants exclusive to the non-MODY group, which includes T2DM and healthy controls. This suggests a possible role in differentiating between these conditions, although its direct impact on disease pathogenesis remains unclear (MosconaNissan2024Whole).

In the context of Parkinson's disease (PD), OR2A42 was identified in a chromosomal region with copy number gains. However, the study did not establish a direct role for OR2A42 in PD, indicating that while genetic variations were observed, their clinical significance in PD requires further investigation (Kim2008Comparative).

Additionally, research on cell-free DNA in cancer diagnostics noted that copy number gains in olfactory receptor genes, including OR2A42, are more common than losses. This finding highlights the potential for OR2A42 to be involved in cancer-related genetic alterations, although specific clinical implications were not detailed (Alcaide2020Evaluating).


## References


1. (MosconaNissan2024Whole) Whole Exome Sequencing characterization of Maturity-Onset Diabetes of the Young (MODY) and Type 2 Diabetes Mellitus patients reveals polygenic features and novel genetic variants of risk for MODY in a Latino population. This article has 0 citations.

[2. (Flegel2013Expression) Caroline Flegel, Stavros Manteniotis, Sandra Osthold, Hanns Hatt, and Günter Gisselmann. Expression profile of ectopic olfactory receptors determined by deep sequencing. PLoS ONE, 8(2):e55368, February 2013. URL: http://dx.doi.org/10.1371/journal.pone.0055368, doi:10.1371/journal.pone.0055368. This article has 286 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0055368)

3. (Mazzei2024Functional) Functional CRISPR-Cas9 knockout screening of the genetic determinants of human fibroblast migration propensity. This article has 0 citations.

[4. (Alcaide2020Evaluating) Miguel Alcaide, Matthew Cheung, Jack Hillman, S. Rod Rassekh, Rebecca J. Deyell, Gerald Batist, Aly Karsan, Alexander W. Wyatt, Nathalie Johnson, David W. Scott, and Ryan D. Morin. Evaluating the quantity, quality and size distribution of cell-free dna by multiplex droplet digital pcr. Scientific Reports, July 2020. URL: http://dx.doi.org/10.1038/s41598-020-69432-x, doi:10.1038/s41598-020-69432-x. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-69432-x)

[5. (Yasi2019Rapid) Emily A. Yasi, Sara L. Eisen, Hanfei Wang, Widianti Sugianto, Anita R. Minniefield, Kaitlyn A. Hoover, Paul J. Branham, and Pamela Peralta-Yahya. Rapid deorphanization of human olfactory receptors in yeast. Biochemistry, 58(16):2160–2166, April 2019. URL: http://dx.doi.org/10.1021/acs.biochem.8b01208, doi:10.1021/acs.biochem.8b01208. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.8b01208)

[6. (Kim2008Comparative) Joong-Seok Kim, Ji-Yeon Yoo, Kwang-Soo Lee, Hye Sung Kim, Jin Soo Choi, Hyoung Kyun Rha, Sung-Vin Yim, and Kweon-Haeng Lee. Comparative genome hybridization array analysis for sporadic parkinson’s disease. International Journal of Neuroscience, 118(9):1331–1345, January 2008. URL: http://dx.doi.org/10.1080/00207450802174522, doi:10.1080/00207450802174522. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/00207450802174522)